$LDOS earnings report

Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance. AlphAI read Leidos Holdings's third quarter of fiscal year 2026 filing as solid. 2 quarters are on record below.

third quarter of fiscal year 2026

AlphAI · Earnings readLDOS · third quarter of fiscal year 2026 · ended October 2, 2026

Leidos Delivers Strong Third Quarter and Enhances Full-Year Guidance

✓Solid quarter

Third-quarter revenue, net income, diluted EPS, adjusted EBITDA and non-GAAP diluted EPS increased year-over-year, Homeland growth and improved profitability supported results, and fiscal 2026 non-GAAP diluted EPS and operating-cash-flow guidance increased. Health revenue and margins declined, quarterly operating cash flow and free cash flow were below the prior-year quarter, and the revenue guidance range was reduced following the SES joint venture adjustment.

Revenue
$4.63B
4% y/y
Intelligence & Digital
$1.55B
1% y/y
Operating margin · non-GAAP
13.1 %
EPS · non-GAAP
$ 3.62
19% y/y
FY26 outlook
$18.00 - $18.20

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended October 2, 2026GAAP$4.63B–4%
Operating income, three months ended October 2, 2026GAAP$553M––
Operating income margin, three months ended October 2, 2026GAAP11.9 %––
Net income, three months ended October 2, 2026GAAP$413M–12%
Net income margin, three months ended October 2, 2026GAAP8.9 %––
Net income attributable to Leidos common stockholders, three months ended October 2, 2026GAAP$410M––
Diluted earnings per share, three months ended October 2, 2026GAAP$ 3.28–16%
Basic earnings per share, three months ended October 2, 2026GAAP$ 3.31––
Non-GAAP operating income, three months ended October 2, 2026non-GAAP$607M––
Non-GAAP operating margin, three months ended October 2, 2026non-GAAP13.1 %––
Non-GAAP net income, three months ended October 2, 2026non-GAAP$455M–14%
Non-GAAP diluted EPS, three months ended October 2, 2026non-GAAP$ 3.62–19%
Adjusted EBITDA, three months ended October 2, 2026non-GAAP$644M–5%
Adjusted EBITDA margin, three months ended October 2, 2026non-GAAP13.9 %––
Net cash provided by operating activities, three months ended October 2, 2026GAAP$523M––
Operating cash flow conversion ratio, three months ended October 2, 2026other128 %––
Non-GAAP free cash flow, three months ended October 2, 2026non-GAAP$476M––
Non-GAAP free cash flow conversion ratio, three months ended October 2, 2026non-GAAP105 %––
Net bookings, three months ended October 2, 2026other$5.5B––
Book-to-bill ratio, three months ended October 2, 2026other1.2––
Backlog, October 2, 2026other$49.6B–4%
Funded backlog, October 2, 2026other$11.1B–22%
Revenue, nine months ended October 2, 2026GAAP$13.59B––
Operating income, nine months ended October 2, 2026GAAP$1.57B––
Net income, nine months ended October 2, 2026GAAP$1.10B––
Diluted earnings per share, nine months ended October 2, 2026GAAP$ 8.67––
Non-GAAP diluted EPS, nine months ended October 2, 2026non-GAAP$ 10.03––
Adjusted EBITDA, nine months ended October 2, 2026non-GAAP$1.89B––
Net cash provided by operating activities, nine months ended October 2, 2026GAAP$1.62B––

Segments

SegmentRevenueq/qy/y
Intelligence & DigitalRecent contract awards and higher volumes and expanded scope across key Intelligence Community programs, offset by reductions in certain federal civilian IT programs.$1.55B–1%
HealthExpected program shifts and reduced volumes on managed health services programs.$1.07B–(12%)
HomelandStrong demand for air traffic management and electric power distribution engineering solutions, as well as $142 million from the acquisition of ENTRUST Solutions.$1.02B–32%
DefenseIncreased demand for defense technology areas including air defense, sensing, and C5ISR systems.$992M–3%

FY26 outlook

  • Revenue$18.00 - $18.20
  • NoteAdjusted EBITDA Margin: Mid 13%
  • NoteNon-GAAP Diluted EPS: $12.50 - $12.70
  • NoteCash Flows Provided by Operating Activities (B): Approximately $1.90

Capital returns

  • $556 million returned to shareholders in the quarter, including $504 million in share repurchases and $52 million as part of a regular quarterly cash dividend program.
  • On October 30, 2026, the Board declared a cash dividend of $0.45 per share, an increase of 4.7% over the prior quarter's dividend amount. The dividend is payable on December 31, 2026, to stockholders of record at the close of business on December 15, 2026.
  • Cash dividends declared per share were $ 0.43 for the three months ended October 2, 2026, compared with $ 0.40 for the three months ended October 3, 2025.
  • Repurchases of stock and other were $ 504 million for the three months ended October 2, 2026, compared with $ 102 million for the three months ended October 3, 2025.

What drove it

  • Quarterly revenue grew due to increased customer demand for defense tech products, air traffic management solutions, and intelligence mission support, as well as the acquisition of ENTRUST Solutions.
  • Profitability was driven by improved program performance and disciplined cost management across the portfolio.
  • GAAP and non-GAAP earnings measures reflected a lower effective tax rate, primarily due to an increase in the federal research tax credit and a decrease in unrecognized tax benefits.
  • The October 5, 2026 closing of the Contribution and Equity Purchase Agreement with Altaris contributed the Security Enterprise Solutions and Industrial Automation businesses to a newly formed joint venture.
  • Trailing-twelve-month book-to-bill of 1.1 resulted in year-over-year growth in total and funded backlog of 4% and 22%, respectively.

Concerns

  • Health revenue decreased by 12% and Health operating income margin declined to 22.5% from 26.8%, driven by expected program shifts and reduced volumes on managed health services programs.
  • Quarterly net cash provided by operating activities declined to $ 523 million from $ 711 million, while non-GAAP free cash flow declined to $ 476 million from $ 680 million.
  • FY26 revenue guidance was adjusted to $18.00 - $18.20 from $18.20 - $18.40 after adjusting for the joint venture and incorporating its year-to-date performance and current outlook.
  • Interest expense, net, increased to $ 67 million in the quarter from $ 51 million in the prior-year quarter.
  • Three-month total operating income margin was 11.9 % compared with 12.0 % in the prior-year quarter.

What to watch

  • Execution of the FY26 guidance range of $18.00 - $18.20 in revenue, Mid 13% adjusted EBITDA margin, $12.50 - $12.70 non-GAAP diluted EPS, and Approximately $1.90 cash flows provided by operating activities.
  • Health program shifts, managed health services volumes, and the segment's operating income margin.
  • Contribution of ENTRUST Solutions, which provided $142 million of Homeland acquisition revenues in the quarter.
  • Conversion of the $49.6 billion backlog and $11.1 billion funded backlog into revenue.
  • Performance after the contribution of the SES businesses to the Altaris joint venture.

Balance sheet and cash flow

  • Cash and cash equivalents were $630 million as of October 2, 2026, compared with $ 1,108 million as of January 2, 2026.
  • Debt was $6.0 billion as of October 2, 2026.
  • Net cash used in investing activities was $ 48 million in the quarter, including $ 47 million in payments for property, equipment and software.
  • Net cash used in financing activities was $ 549 million in the quarter, compared with $ 595 million used in the prior-year quarter.
  • Nine-month acquisition of a business, net of cash acquired, was $ 2,338 million, compared with $ 292 million in the prior-year nine-month period.
  • Nine-month net cash used in investing activities was $ 2,445 million, compared with $ 372 million in the prior-year nine-month period.

Analysis

Leidos reported third-quarter revenue of $4.6 billion, up 4% year-over-year, with GAAP net income of $413 million and diluted EPS of $3.28. Non-GAAP diluted EPS increased 19% to $3.62, while adjusted EBITDA rose 5% to $644 million and adjusted EBITDA margin increased to 13.9% from 13.8%. Management attributed revenue growth to demand for defense technology products, air traffic management solutions and intelligence mission support, alongside the ENTRUST Solutions acquisition. Earnings also reflected a lower effective tax rate, primarily from a higher federal research tax credit and lower unrecognized tax benefits.

Segment performance was uneven. Homeland revenue grew 32% to $1.02 billion, including $142 million from ENTRUST Solutions, and its GAAP operating income margin rose to 7.9% from 6.5%; non-GAAP operating margin increased to 11.3% from 7.5%. Intelligence & Digital revenue rose 1% to $1.55 billion and GAAP operating income margin improved to 11.1% from 9.2%. Defense revenue increased 3% to $992 million and margin increased to 8.7% from 8.2%. Health was the offset, with revenue down 12% to $1.07 billion and GAAP operating income margin down to 22.5% from 26.8% because of expected program shifts and reduced managed-health-services volumes.

Cash generation remained positive but was lower than the prior-year quarter. Operating cash flow was $523 million, compared with $711 million, and non-GAAP free cash flow was $476 million, compared with $680 million. Leidos returned $556 million to shareholders during the quarter, including $504 million of share repurchases and $52 million in dividends. Cash and cash equivalents were $630 million and debt was $6.0 billion as of October 2, 2026. The Board declared a $0.45 per-share dividend on October 30, 2026, which the release says is 4.7% above the prior quarter's dividend amount.

Demand indicators were constructive. Quarterly net bookings were $5.5 billion, producing a 1.2 book-to-bill ratio, and backlog was $49.6 billion, including $11.1 billion funded. Trailing-twelve-month book-to-bill of 1.1 supported year-over-year total backlog growth of 4% and funded backlog growth of 22%. Key awards spanned intelligence, air traffic management, defense health, cyber, space sensing and naval systems.

Leidos adjusted FY26 guidance after the October 5 closing of the contribution of its SES businesses to a newly formed joint venture with Altaris. The revenue range moved to $18.00 - $18.20 from $18.20 - $18.40, while adjusted EBITDA margin remained Mid 13%. The non-GAAP diluted EPS range increased to $12.50 - $12.70 from $12.20 - $12.50, and cash flows provided by operating activities increased to Approximately $1.90 from Approximately $1.85. The central reporting issues are the adjusted revenue outlook, sustained Health pressure, the lower quarterly cash flow versus the prior-year period, and whether higher-margin Homeland commercial work and program execution improvements continue to support profitability.

Management, verbatim

Leidos delivered another quarter of strong financial performance, allowing us to enhance our 2026 guidance for the third consecutive quarter.

Tom Bell, Chief Executive Officer

Our sustained momentum reflects the strength of our focused team, united behind our NorthStar 2030 strategy and committed to delivering on our customers’ most critical missions.

Tom Bell, Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Gross profit was not reported.
  • Effective tax rate was not reported.
  • Prior-quarter financial metrics were not reported for the third quarter of fiscal 2026.
  • Forward guidance for gross margin, operating expenses and tax rate was not reported.
  • Segment revenue sequential changes were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

second quarter of fiscal year 2026

AlphAI · Earnings readLDOS · second quarter of fiscal year 2026 · ended July 3, 2026

Leidos Delivers Strong Second Quarter and Enhances Full-Year Guidance

✓Solid quarter

Revenue grew 7% year-over-year, operating cash flow and non-GAAP free cash flow were strong, and the company raised fiscal year 2026 revenue, non-GAAP diluted EPS, and operating cash flow guidance. GAAP net income, GAAP diluted EPS, net income margin, adjusted EBITDA, and adjusted EBITDA margin declined year-over-year.

Revenue
$4.56B
up 7% y/y
EPS · non-GAAP
$3.26
up 2% y/y
FY26 outlook
$18.20 - $18.40

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
RevenuesGAAP$4.56B–up 7%
Net incomeGAAP$356M–down 9%
Net income marginGAAP7.8%––
Diluted earnings per share (EPS)GAAP$2.81 per diluted share–down 7%
Adjusted EBITDAnon-GAAP$631M–down 2%
Adjusted EBITDA marginnon-GAAP13.8%––
Non-GAAP net incomenon-GAAP$413M–decreased 1% year-over-year
Non-GAAP diluted EPSnon-GAAP$3.26–up 2%
Net cash provided by operating activitiesGAAP$793M––
Operating cash flow conversion ratioother224%––
Non-GAAP Free Cash Flownon-GAAP$761M––
Free cash flow conversion rationon-GAAP185%––
Net bookingsother$4.9B––
Book-to-bill ratioother1.1––
Backlogother$48.7B–5%
Funded backlogother$10.2B–44%
Trailing-twelve-month book-to-billother1.1––

FY26 outlook

  • Revenue$18.20 - $18.40
  • NoteAdjusted EBITDA Margin: Mid 13%
  • NoteNon-GAAP Diluted EPS: $12.20 - $12.50
  • NoteCash Flows Provided by Operating Activities (B): Approximately $1.85

Capital returns

  • $127 million returned to shareholders
  • $72 million in share repurchases
  • $55 million as part of a regular quarterly cash dividend program

What drove it

  • Revenues grew year-over-year due to increased customer demand for defense tech products, energy and air traffic management solutions, and intelligence mission support.
  • Revenues were up 7% compared to the second quarter of 2025, including 4% organically.
  • Profitability in the current quarter reflected excellent program execution and disciplined cost management across the portfolio.
  • Quarterly bookings included a $475 million follow-on AIS PIS contract, a $456 million GSA Military OneSource contract, a $350 million U.S. Air Force Electronic Warfare Mission Support contract modification, a potential 30-month, $325 million DHA RHRP 3.1 contract modification, a five-year, $270 million CBP MEM Systems IDIQ contract, and an $88 million NSWC MACH-TB 2.0 contract.

Concerns

  • Net income and diluted EPS for the quarter reflect $29 million in costs associated with the acquisition of ENTRUST Solutions Group and the pending joint venture with Analogic Corporation, as well as restructuring costs associated with the NorthStar 2030 re-alignment.
  • Adjusted EBITDA margin of 13.8% decreased from 15.2% in the second quarter of 2025.
  • Profitability in the year-ago quarter benefited from several one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs.

What to watch

  • Execution against FY26 revenue guidance of $18.20 - $18.40.
  • Execution against FY26 non-GAAP diluted EPS guidance of $12.20 - $12.50 and adjusted EBITDA margin guidance of Mid 13%.
  • Delivery against FY26 cash flows provided by operating activities guidance of Approximately $1.85.
  • Conversion of the $48.7 billion backlog, including $10.2 billion of funded backlog, into revenue.
  • Progress of the pending joint venture with Analogic Corporation and the acquisition of ENTRUST Solutions Group.

Balance sheet and cash flow

  • For the quarter, Leidos used $38 million in investing activities, including $32 million in property, equipment and software payments.
  • Leidos used $423 million in financing activities, consisting primarily of $300 million in debt paydown and $127 million returned to shareholders.
  • As of July 3, 2026, Leidos had $748 million in cash and cash equivalents and $6.0 billion of debt.

Analysis

Leidos reported second-quarter fiscal year 2026 revenue of $4,558 million, up 7% year-over-year, including 4% organic growth. Management attributed the growth to increased demand for defense tech products, energy and air traffic management solutions, and intelligence mission support. The company also reported $4.9 billion of net bookings, a 1.1 book-to-bill ratio, and $48.7 billion of backlog, with funded backlog of $10.2 billion growing 44% year-over-year.

Earnings performance was weaker than revenue growth. GAAP net income was $356 million, down 9%, and GAAP diluted EPS was $2.81 per diluted share, down 7%. Net income margin declined to 7.8% from 9.2%. The company identified $29 million of costs related to the Entrust acquisition, the pending Analogic joint venture, and NorthStar 2030 restructuring. Non-GAAP net income declined 1% to $413 million, while non-GAAP diluted EPS increased 2% to $3.26.

Profitability metrics also moved lower against a year-ago period that included one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs. Adjusted EBITDA fell 2% to $631 million and adjusted EBITDA margin declined to 13.8% from 15.2%. Management nevertheless cited excellent program execution and disciplined cost management across the portfolio.

Cash generation was a principal strength. Net cash provided by operating activities was $793 million, with an operating cash flow conversion ratio of 224%. Non-GAAP Free Cash Flow was $761 million and the free cash flow conversion ratio was 185%. The company used $300 million for debt paydown and returned $127 million to shareholders, including $72 million of share repurchases and $55 million in regular quarterly cash dividends.

Leidos raised the low end of FY26 revenue guidance to $18.20 - $18.40 from $18.00 - $18.40, raised the low end of non-GAAP diluted EPS guidance to $12.20 - $12.50 from $12.10 - $12.50, and increased expected cash flows provided by operating activities to Approximately $1.85 from Approximately $1.80. Adjusted EBITDA margin guidance remained Mid 13%. The central points for the balance of the year are conversion of increased backlog, sustained cash generation, margin execution, and the financial effects of Entrust, the pending Analogic joint venture, and NorthStar 2030 restructuring.

Management, verbatim

I'm pleased to report another strong quarter for Leidos. In addition to achieving milestones for revenue and cash, we booked $5 billion of contract awards. We’re seeing meaningful growth emerge across our Defense Tech, Energy Infrastructure, and Cyber growth pillars. And we have greater visibility into the long-term role of our Managed Healthcare pillar. The strength of our balanced portfolio allows us to enhance our 2026 guidance for revenues, earnings, and cash.

Tom Bell, Chief Executive Officer

Not in the filing

stated, not guessed
  • Segment revenue, segment year-over-year changes, segment quarter-over-quarter changes, and segment profitability were not provided in the supplied filing text.
  • GAAP gross profit and gross margin were not provided in the supplied filing text.
  • GAAP operating income, operating margin, and operating expenses were not provided in the supplied filing text.
  • Income tax expense and effective tax rate were not provided in the supplied filing text.
  • Prior-quarter comparisons for reported financial metrics were not provided in the supplied filing text.
  • Prior-year amount for non-GAAP net income was not provided on its own line in the supplied filing text.
  • Prior-year cash flow and free cash flow comparisons were not provided in the supplied filing text.
  • FY26 guidance for gross margin, operating expenses, and tax rate was not provided in the supplied filing text.
  • A previous earnings release outlook was not provided, so no actual-versus-prior-guidance comparison is included.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about LDOS earnings dates

When is Leidos Holdings's next earnings date?
AlphAI has no date for LDOS yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.